Novartis to Acquire Presbyopia Drug Developer Encore Vision

Wednesday, December 21 2016 | 00 h 00 min | News

Novartis Ophthalmology announced they have entered into an agreement to acquire a topical treatment for presbyopia from Encore Vision Inc., a privately-held Texas based company. The announcement calls the new investigational product EV06 a “potentially disruptive innovation” and the first-in-class topical treatment for presbyopia.

EV06 has completed a phase I/II proof of concept study. The pro-drug restores the bilateral micro-fluidics of the crystalline lens through a biochemical mechanism of action.

In 2016, Novartis combined its retina medicines business with the Alcon pharmaceuticals business, now operating as one Ophthalmology franchise under Novartis Pharmaceuticals.

View the Novartis Press release here.

View Encore Vision’s discussion of the drug and clinical trials HERE.

Featured Posts

Optik Sept-Oct 2026 issue Voila Centennial F-8864

Lightweight Strength, Modern Style

VX Titanium combines 100% titanium construction with lightweight comfort, durability and contemporary styling across 13 men’s and women’s designs.

Learn More

Academy 2026 Anaheim Showcases Research, Innovation and Leaders Shaping the Future of Eye Care

Academy 2026 Anaheim showcased major research, innovation and leadership in optometry, featuring landmark studies, new Fellows and advances shaping the future of eye care.

Read more

Zeiss Myopia Summit 2026-EN

ZEISS Myopia Innovation Summit Turns Evidence into Action in Vancouver

ZEISS gathered eye care professionals in Vancouver for the Myopia Innovation Summit, introducing MyoActive and showcasing evidence based strategies for myopia management.

Read more

Optometry Practice Succession Planning

Succession Made Simple

Learn how early optometry practice succession planning can improve practice value, reduce owner dependence, protect tax eligibility, and create a smoother transition.

Read more

CIBC Commercial Banking Steps Into Canadian Optometry

CIBC Commercial Banking is stepping into Canadian optometry through a new collaboration with Eye Care Business Canada, debuting with a webinar on buying an optometric practice.

Read more

Optik Sept-Oct 2026 issue Voila Centennial F-8864

Lightweight Strength, Modern Style

VX Titanium combines 100% titanium construction with lightweight comfort, durability and contemporary styling across 13 men’s and women’s designs.

Learn More

Academy 2026 Anaheim Showcases Research, Innovation and Leaders Shaping the Future of Eye Care

Academy 2026 Anaheim showcased major research, innovation and leadership in optometry, featuring landmark studies, new Fellows and advances shaping the future of eye care.

Read More

Zeiss Myopia Summit 2026-EN

ZEISS Myopia Innovation Summit Turns Evidence into Action in Vancouver

ZEISS gathered eye care professionals in Vancouver for the Myopia Innovation Summit, introducing MyoActive and showcasing evidence based strategies for myopia management.

Read More

Optometry Practice Succession Planning

Succession Made Simple

Learn how early optometry practice succession planning can improve practice value, reduce owner dependence, protect tax eligibility, and create a smoother transition.

Read More

CIBC Commercial Banking Steps Into Canadian Optometry

CIBC Commercial Banking is stepping into Canadian optometry through a new collaboration with Eye Care Business Canada, debuting with a webinar on buying an optometric practice.

Read More

Optik Sept-Oct 2026 issue Voila Centennial F-8864

Lightweight Strength, Modern Style

VX Titanium combines 100% titanium construction with lightweight comfort, durability and contemporary styling across 13 men’s and women’s designs.

Learn More

Academy 2026 Anaheim Showcases Research, Innovation and Leaders Shaping the Future of Eye Care

Academy 2026 Anaheim showcased major research, innovation and leadership in optometry, featuring landmark studies, new Fellows and advances shaping the future of eye care.

Read more

Zeiss Myopia Summit 2026-EN

ZEISS Myopia Innovation Summit Turns Evidence into Action in Vancouver

ZEISS gathered eye care professionals in Vancouver for the Myopia Innovation Summit, introducing MyoActive and showcasing evidence based strategies for myopia management.

Read more

Optometry Practice Succession Planning

Succession Made Simple

Learn how early optometry practice succession planning can improve practice value, reduce owner dependence, protect tax eligibility, and create a smoother transition.

Read more

CIBC Commercial Banking Steps Into Canadian Optometry

CIBC Commercial Banking is stepping into Canadian optometry through a new collaboration with Eye Care Business Canada, debuting with a webinar on buying an optometric practice.

Read more

Optik Sept-Oct 2026 issue Voila Centennial F-8864

Lightweight Strength, Modern Style

VX Titanium combines 100% titanium construction with lightweight comfort, durability and contemporary styling across 13 men’s and women’s designs.

Learn More

Academy 2026 Anaheim Showcases Research, Innovation and Leaders Shaping the Future of Eye Care

Academy 2026 Anaheim showcased major research, innovation and leadership in optometry, featuring landmark studies, new Fellows and advances shaping the future of eye care.

Read more

Zeiss Myopia Summit 2026-EN

ZEISS Myopia Innovation Summit Turns Evidence into Action in Vancouver

ZEISS gathered eye care professionals in Vancouver for the Myopia Innovation Summit, introducing MyoActive and showcasing evidence based strategies for myopia management.

Read more

Optometry Practice Succession Planning

Succession Made Simple

Learn how early optometry practice succession planning can improve practice value, reduce owner dependence, protect tax eligibility, and create a smoother transition.

Read more

CIBC Commercial Banking Steps Into Canadian Optometry

CIBC Commercial Banking is stepping into Canadian optometry through a new collaboration with Eye Care Business Canada, debuting with a webinar on buying an optometric practice.

Read more